Riverbridge Partners LLC Charles River Laboratories International, Inc. Transaction History

Riverbridge Partners LLC

$7.23 Billion
Q3 2024

A detailed history of Riverbridge Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Riverbridge Partners LLC holds 266,447 shares of CRL stock, worth $53.6 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

266,447

Previous 289,272 7.89%

Holding current value

$53.6 Million

Previous $59.8 Million 12.17%

% of portfolio

0.73%

Previous 0.84%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$187.96 - $245.29 $4.29 Million - $5.6 Million	-22,825 Reduced 7.89%	266,447 $52.5 Million
Q2 2024 Jul 17, 2024	SELL	$206.39 - $268.73 $2.99 Million - $3.9 Million	-14,506 Reduced 4.78%	289,272 $59.8 Million
Q1 2024 Apr 26, 2024	BUY	$203.52 - $273.43 $628,469 - $844,351	3,088 Added 1.03%	303,778 $82.3 Million
Q4 2023 Feb 15, 2024	SELL	$164.52 - $238.84 $2.36 Million - $3.43 Million	-14,368 Reduced 4.56%	300,690 $71.1 Million
Q4 2023 Jan 24, 2024	SELL	$164.52 - $238.84 $2.37 Million - $3.44 Million	-14,387 Reduced 5.23%	260,595 $61.6 Million
Q3 2023 Feb 15, 2024	BUY	$194.44 - $217.61 $10.6 Million - $11.9 Million	54,463 Added 20.9%	315,058 $61.7 Million
Q3 2023 Oct 16, 2023	SELL	$194.44 - $217.61 $8.98 Million - $10.1 Million	-46,198 Reduced 14.38%	274,982 $53.9 Million
Q2 2023 Jul 25, 2023	BUY	$183.71 - $210.25 $4.08 Million - $4.66 Million	22,186 Added 7.42%	321,180 $67.5 Million
Q1 2023 Apr 21, 2023	SELL	$191.89 - $259.92 $348,088 - $471,494	-1,814 Reduced 0.6%	298,994 $60.3 Million
Q4 2022 Jan 11, 2023	SELL	$197.11 - $250.07 $3.63 Million - $4.6 Million	-18,412 Reduced 5.77%	300,808 $65.5 Million
Q3 2022 Oct 26, 2022	BUY	$182.44 - $250.54 $16 Million - $22 Million	87,669 Added 37.86%	319,220 $62.8 Million
Q2 2022 Aug 29, 2022	SELL	$204.13 - $302.4 $8.27 Million - $12.2 Million	-40,492 Reduced 14.88%	231,551 $49.5 Million
Q2 2022 Jul 11, 2022	BUY	$204.13 - $302.4 $2.66 Million - $3.94 Million	13,022 Added 5.03%	272,043 $58.2 Million
Q1 2022 Apr 20, 2022	BUY	$255.51 - $362.11 $22.5 Million - $31.9 Million	88,183 Added 51.62%	259,021 $73.6 Million
Q4 2021 Jan 14, 2022	BUY	$351.38 - $448.68 $1.95 Million - $2.49 Million	5,553 Added 3.36%	170,838 $64.4 Million
Q3 2021 Oct 26, 2021	SELL	$372.64 - $458.3 $279,852 - $344,183	-751 Reduced 0.45%	165,285 $68.2 Million
Q2 2021 Jul 26, 2021	BUY	$294.17 - $371.65 $3.13 Million - $3.96 Million	10,657 Added 6.86%	166,036 $61.4 Million
Q1 2021 Apr 21, 2021	BUY	$249.67 - $299.48 $38.8 Million - $46.5 Million	155,379 New	155,379 $45 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.

Account

Riverbridge Partners LLC Charles River Laboratories International, Inc. Transaction History